SCHEMBL952092

SCHEMBL952092

CCC(=O)OC(=O)C(C)Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.37
ALDH1A1 P00352 7/20 0.35
MGAM O43451 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
SOAT1 P35610 1/20 0.35
HIF1A Q16665 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP1A2 P05177 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
BLM P54132 1/20 0.33
WRN Q14191 1/20 0.33
LMNA P02545 3/20 0.33
TRPA1 O75762 1/20 0.32
ALOX15 P16050 1/20 0.32
MAPT P10636 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Bromide SCHEMBL27970187 0.91 NAAA (0.32) NAAAALDH1A1MGAMGAASI
SCHEMBL27860198 0.84 ALDH1A1 (0.58) NAAAALDH1A1MGAMGAASI
SCHEMBL951592 0.83 FAAH (0.30)
SCHEMBL28112048 0.82 NAAA (0.38) NAAAALDH1A1MGAMGAASI
SCHEMBL3008985 0.81 KDM4E (0.30) CYP1A2LMNA
SCHEMBL952090 0.81 TSHR (0.38) ALDH1A1SOAT1LMNATSHR
SCHEMBL386957 0.79 NAAA (0.39) NAAAALDH1A1MGAMGAASI
SCHEMBL28622651 0.79 ALDH1A1 (0.36) NAAAALDH1A1TRPA1
SCHEMBL15259527 0.78 NAAA (0.35) NAAAALDH1A1MGAMGAASI
SCHEMBL288874 0.77 NAAA (0.38) NAAAALDH1A1MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119505178-B Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof 浙江工业大学 2025-04-04 CN claimed
CN-119505178-A Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof 浙江工业大学 2025-02-25 CN claimed
CN-118653302-B Preparation method of long-acting antibacterial cellulose material 北京林业大学 2024-11-15 CN claimed
CN-118653302-A Preparation method of long-acting antibacterial cellulose material 北京林业大学 2024-09-17 CN claimed
CN-117624613-A Degradable phosphorus/silicon composite antibacterial/flame-retardant material and preparation method thereof 浙江工业大学 2024-03-01 CN claimed
CN-119505178-B Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof 浙江工业大学 2025-04-04 CN disclosed
CN-119505178-A Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof 浙江工业大学 2025-02-25 CN disclosed
CN-118653302-B Preparation method of long-acting antibacterial cellulose material 北京林业大学 2024-11-15 CN disclosed
CN-118653302-A Preparation method of long-acting antibacterial cellulose material 北京林业大学 2024-09-17 CN disclosed
CN-117624613-A Degradable phosphorus/silicon composite antibacterial/flame-retardant material and preparation method thereof 浙江工业大学 2024-03-01 CN disclosed
US-20210387990-A1 METHOD FOR PRODUCING DIMETHOXYBENZENE COMPOUND TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-12-16 US disclosed
US-20210388002-A1 DIMETHOXYBENZENE COMPOUND ANALOGS, METHODS FOR ANALYZING SAID COMPOUNDS AND STANDARD PRODUCTS OF SAID COMPOUNDS TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-12-16 US disclosed
US-4477443-A INCREASED ANTIBIOTIC ACTIVITY Zaidan Hojin Biselbutsu Kagaku Kenkyu Kai (Microbial Chemistry Research Foundation) (JP) 1984-10-16 US disclosed
EP-0070170-A1 Tylosin derivatives, their preparation and pharmaceutical compositions containing them ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1983-01-19 EP disclosed
US-4255594-A Hydrogenation of halogen-containing carboxylic anhydrides ALLIED CHEMICAL CORPORATION (US) 1981-03-10 US disclosed
US-4203898-A ANTICARCINOGENIC ELI LILLY AND COMPANY (US) 1980-05-20 US disclosed
US-4192871-A ANAESTHETICS - STEROIDS GLAXO LABORATORIES LIMITED (GB) 1980-03-11 US disclosed
US-4015995-A CATALYST COMPRISING ACID-RELEASING COMPOUND AND A BASE CHEVRON RESEARCH COMPANY (US) 1977-04-05 US disclosed
US-3958931-A Wool dyeing with epihalohydrin or chloroacetamide quarternized polyglycolamine assisted dye solution CIBA-GEIGY AG (CH) 1976-05-25 US disclosed
US-3943084-A Method for delaying the setting of and acid-settable liquid in a terrestrial zone CHEVRON RESEARCH COMPANY (US) 1976-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387990-A1 METHOD FOR PRODUCING DIMETHOXYBENZENE COMPOUND CYP1B1, PAH, CYP4B1 NAAA 839/4885ALDH1A1 40/4885MGAM 3984/4885
US-20210388002-A1 DIMETHOXYBENZENE COMPOUND ANALOGS, METHODS FOR ANALYZING SAID COMPOUNDS AND STANDARD PRODUCTS OF SAID COMPOUNDS DDC, PAH, DDT NAAA 1442/4885ALDH1A1 12/4885MGAM 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.